RecruitingPhase 1NCT06305910

CD200AR-L and Allogeneic Tumor Lysate Vaccine Immunotherapy for Recurrent HGG and Newly Diagnosed DMG/DIPG in Children and Young Adults

Studying Diffuse intrinsic pontine glioma

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
OX2 Therapeutics
Intervention
Treatment with CD200AR-L(drug)
Enrollment
24 enrolled
Eligibility
2-25 years · All sexes
Timeline
20242027

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06305910 on ClinicalTrials.gov

Other trials for Diffuse intrinsic pontine glioma

Additional recruiting or active studies for the same condition.

See all trials for Diffuse intrinsic pontine glioma

← Back to all trials